Correlation Between Passage Bio and Cerevel Therapeutics
Can any of the company-specific risk be diversified away by investing in both Passage Bio and Cerevel Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Passage Bio and Cerevel Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Passage Bio and Cerevel Therapeutics Holdings, you can compare the effects of market volatilities on Passage Bio and Cerevel Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Passage Bio with a short position of Cerevel Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Passage Bio and Cerevel Therapeutics.
Diversification Opportunities for Passage Bio and Cerevel Therapeutics
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Passage and Cerevel is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Passage Bio and Cerevel Therapeutics Holdings in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Cerevel Therapeutics and Passage Bio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Passage Bio are associated (or correlated) with Cerevel Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Cerevel Therapeutics has no effect on the direction of Passage Bio i.e., Passage Bio and Cerevel Therapeutics go up and down completely randomly.
Pair Corralation between Passage Bio and Cerevel Therapeutics
If you would invest 108.00 in Passage Bio on December 5, 2024 and sell it today you would lose (65.00) from holding Passage Bio or give up 60.19% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Flat |
Strength | Insignificant |
Accuracy | 0.0% |
Values | Daily Returns |
Passage Bio vs. Cerevel Therapeutics Holdings
Performance |
Timeline |
Passage Bio |
Cerevel Therapeutics |
Risk-Adjusted Performance
Very Weak
Weak | Strong |
Passage Bio and Cerevel Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Passage Bio and Cerevel Therapeutics
The main advantage of trading using opposite Passage Bio and Cerevel Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Passage Bio position performs unexpectedly, Cerevel Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Cerevel Therapeutics will offset losses from the drop in Cerevel Therapeutics' long position.Passage Bio vs. Black Diamond Therapeutics | Passage Bio vs. Revolution Medicines | Passage Bio vs. Stoke Therapeutics | Passage Bio vs. Cabaletta Bio |
Cerevel Therapeutics vs. Avidity Biosciences | Cerevel Therapeutics vs. Revolution Medicines | Cerevel Therapeutics vs. Day One Biopharmaceuticals | Cerevel Therapeutics vs. SpringWorks Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.
Other Complementary Tools
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules |